Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Compassoft was a specialized software provider focused on governance, risk, and compliance (GRC) solutions for the life sciences and pharmaceutical industries. The company's technology addressed the regulatory challenges associated with End User Computing (EUC) applications, such as spreadsheets and databases, which are critical for clinical data and financial reporting. Its flagship products, including Enterprise, EXChecker, and DaCS, enabled organizations to maintain audit trails, version control, and electronic signatures in compliance with FDA 21 CFR Part 11. Compassoft was acquired by Finsbury Solutions in 2009, and its technology was later integrated into the CIMCON Software portfolio following a subsequent acquisition in 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Compassoft.